The in vitro rhLf-mediated inhibition of cancer proliferation was associated to up-regulation of NF-kβ signaling as well as to the down-regulation of pro-inflammatory and pro-metastatic cytokines, including IL-8, IL-6, granulocyte macrophage colony-stimulating factor and TNF-α. The gene discussed is IL6; the disease is cancer.